default author photo
SCHOLARLY PAPERS

2

DOWNLOADS

311

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa

Number of pages: 24 Posted: 26 Mar 2024
Center for Family Health Research Zambia (CFHRZ), Government of Uganda - Uganda Virus Research Institute (UVRI), University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Oxford, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, University of Oxford, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), IAVI, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of Oxford, IAVI, Imperial College London - IAVI Human Immunology Laboratory, London School of Hygiene & Tropical Medicine - Uganda Research Unit, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, affiliation not provided to SSRN, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), affiliation not provided to SSRN, Center for Family Health Research Zambia (CFHRZ), MRC/UVRI & LSHTM Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, International AIDS Vaccine Initiative, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, University of Nairobi, IAVI, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, Oxus Technologies Limited, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Nairobi, University of Nairobi, UVRI-IAVI HIV Vaccine Program, University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of California, San Francisco (UCSF) - Department of Medicine, IAVI, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Oxford, Imperial College London - IAVI Human Immunology Laboratory, University of Oxford - Oxford Vaccine Group, International AIDS Vaccine Initiative, Imperial College London - Department of Infectious Disease, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Center for Family Health Research Zambia (CFHRZ), IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme and University of Oxford - The Jenner Institute
Downloads 185 (409,459)

Abstract:

Loading...

T cells, T-cell vaccine, HIV vaccine: conserved regions, phase I trial, HIVconsvX, ChAdOx1, MVA, vaccine safety, vaccine immunogenicity, clinical trial, virus inhibition assay, HIV-1

2.

A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomised, Factorial, Non-Inferiority Trial

Number of pages: 31 Posted: 01 May 2025
University College London - MRC Clinical Trials Unit, Medical Research Council Clinical Trials Unit at UCL, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Muhimbili University of Health and Allied Sciences, South African Medical Research Council, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, University College London - MRC Clinical Trials Unit, Assistance Publique-Hôpitaux de Paris - Hôpital Saint-Louis, Imperial College London, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, London School of Hygiene and Tropical Medicine - Uganda Research Unit, EuroVacc Foundation, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, IAVI, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Muhimbili University of Health and Allied Sciences, Medical Research Council Clinical Trials Unit at UCL, South African Medical Research Council, University College London - MRC Clinical Trials Unit, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, IAVI, Imperial College London, South African Medical Research Council, International AIDS Vaccine Initiative, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, Medical Research Council Clinical Trials Unit at UCL, IAVI, South African Medical Research Council, Muhimbili University of Health and Allied Sciences, Muhimbili University of Health and Allied Sciences, Muhimbili University of Health and Allied Sciences, National Institute for Medical Research (NIMR), Eastern Virginia Medical School - CONRAD, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Imperial College London, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Government of Uganda - Uganda Virus Research Institute (UVRI), South African Medical Research Council, South African Medical Research Council and South African Medical Research Council
Downloads 126 (572,948)

Abstract:

Loading...

HIV, Pre-exposure prophylaxis, Prevention, Risk of HIV infection, F/TAF